TWA
GTHX

TCI Wealth Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

TCI Wealth Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-388
Closed -$4K – 2515
2021
Q4 		$4K Buy
+388
New +$4.94K ﹤0.01% 1940

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TCI Wealth Advisors's GTHX Position: Q1 2022 in Review

TCI Wealth Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2022, closing a stake of 388 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in GTHX in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 115 funds tracked by Wall St. Rank hold GTHX as of Q1 2022.

  • TCI Wealth Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 388 G1 Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • TCI Wealth Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $4K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.